| abstract |
The invention relates to a serum marker MMP-7-based biliary atresia diagnosis kit, the diagnosis kit comprises an anti-human MMP-7 monoclonal antibody coated ELISA plate, a negative control solution, a positive control solution, an enzyme labeling reagent, an enzyme substrate solution, a blocking solution, a sample diluent, a washing solution and a stopping solution. Compared with the prior art, the present invention provides a novel sensitive, safe, reliable and easily-operated commercial kit for quantitatively detecting the level of MMP-7 in human serum, which is helpful for early diagnosis of BA; the BA diagnosis sensitivity of the serum biomarker protein MMP-7 is 100%, and the BA diagnosis specificity is 95.6%, the kit has the characteristics of high specificity and high sensitivity; the kit improves the early diagnosis rate of BA, reduces misdiagnosis, and improves the own liver survival rate of the BA. |